Sinovac Biotech Ltd (SVA)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.64B
EV to revenue ratio (TTM)
0.03
EV to ebitda
0.04
Financial Performance
Revenue (TTM)
$0.51B
Gross profit (TTM)
$0.44B
EBITDA
$0.22B
Profitability
Operating margin (TTM)
42.30%
Profit margin
21.60%
Return on assets (TTM)
11.50%
Return on equity (TTM)
25.20%
Per Share Metrics
Revenue per share (TTM)
$5.16
EPS
$0.97
Diluted EPS (TTM)
$0.97
Book value
$7.52
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
6.66
Trailing P/E
6.66
Forward P/E
357.14
PEG ratio
30
Price to sales ratio (TTM)
1.83
Price to book ratio (TTM)
1.82
Growth
Quarterly earnings growth (YoY)
303.70%
Quarterly revenue growth (YoY)
354.80%
Analyst Sentiment
Strong buy
n/a
Buy
n/a
Hold
n/a
Sell
n/a
Strong sell
n/a
Risk & Volatility
Beta
0.06